(Q50475666)

14 March 2018

title

A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial. (English)

1 reference

14 March 2018

author name string

Devan V Mehrotra

series ordinal

1

1 reference

14 March 2018

Xiaoming Li

series ordinal

2

1 reference

14 March 2018

Peter B Gilbert

series ordinal

3

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 September 2006

1 reference

14 March 2018

published in

Biometrics

1 reference

14 March 2018

volume

62

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

893-900

1 reference

14 March 2018

HIV vaccine design and the neutralizing antibody problem

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Reduction in burden of illness: a new efficacy measure for prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Multivariate tests for multiple endpoints in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Principal stratification in causal inference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Clinical trials of HIV vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Comparisons of two-part models with competitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Procedures for comparing samples with multiple endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Identifiability and exchangeability for direct and indirect effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Estimating causal effects of treatments in randomized and nonrandomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Testing for treatment differences with dropouts present in clinical trials--a composite approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

An improved Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2005.00516.X

10.1111/J.1541-0420.2005.00516.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018